VITARIS
VITARIS is a NATO defense supplier classified by WULFRN as a defense medical supplier based on dominant award activity. WULFRN tracks 1 disclosed contract wins from 1+ buyers across 1 NATO country. No new contracts in the last 12 months. Records flow daily from TED, Doffin, NSPA, NCIA, and SAM.gov.
Recent contract wins (last 12 months — 0)
No disclosed wins in the last 12 months.
Top buyers
| Buyer | Awards | Disclosed |
|---|---|---|
| Conseil Départemental des Yvelines | 1 | — |
Domains won
Geographic footprint
Inferred country
- France defense market →
- France × Medical →
- Country inferred from majority of award activity, not company registry.
Top buyers
Related medical suppliers
- SMS medipool AG · 9 awards
- ratiopharm GmbH · 8 awards
- NOWEDA Arzneimittel AG · 7 awards
- PAUL HARTMANN AG · 6 awards
- STADAPHARM GmbH · 6 awards
- Philips GmbH · 6 awards
Frequently asked questions
How many defense contracts has VITARIS won?
WULFRN has tracked 1 awarded defense contracts to VITARIS across 0 years.
Which defense buyers does VITARIS sell to?
VITARIS's top buyers by disclosed value are Conseil Départemental des Yvelines. WULFRN tracks contracts from 1+ distinct buyers for this company.
What defense domains does VITARIS supply?
VITARIS has won contracts across 1 defense domain. The largest by award count are Medical (1). WULFRN classifies the company's primary sector as "Defense medical supplier" based on the dominant domain.
Which countries does VITARIS win contracts in?
VITARIS has won contracts from buyers in 1 NATO country: France (1).
What is the total disclosed value of VITARIS's defense contracts?
VITARIS has no awards with disclosed contract values in WULFRN's dataset. Many NATO defense contracts redact contract amounts.
Is VITARIS an active NATO defense supplier?
VITARIS's last disclosed award is —. No new awards have been tracked in the last 12 months.
Who competes with VITARIS in Medical procurement?
Other medical suppliers ranked by award count in WULFRN's dataset: SMS medipool AG (9), ratiopharm GmbH (8), NOWEDA Arzneimittel AG (7), PAUL HARTMANN AG (6), STADAPHARM GmbH (6).
Methodology & sources
Records on this page are aggregated daily from TED (EU/EEA), Doffin (Norway), NSPA and NCIA (NATO supranational), SAM.gov (US DoD), and the four other Nordic national portals. Award winners are matched by exact string from the source publication; minor variants (legal-form suffixes, transliteration) may not roll up to a single profile. Country of registration is inferred from the majority of the company's buyer-country distribution — WULFRN does not query a company registry, so this field reflects market activity, not corporate domicile. Only 0 of 1 awards (0%) disclose contract value publicly; use award counts (not cumulative value) when comparing companies. See the about page for the full pipeline and the glossary for term definitions.
By Vilhelm Drosjer, founder, WULFRN · Last updated 2026-05-25 · Data refreshed daily 06:00 UTC.
Track VITARIS in WULFRN
Sign up free to follow this supplier's win patterns, buyer relationships, and domain footprint.